ADA Scientific Sessions 2026
5–8 Jun 2026New OrleansDiabetes supplement2,082 abstracts · 456 worth reading
Abstracts
ADA Scientific Sessions 2026 AbstractHuman trial
Semaglutide Reduces Multiorgan Proteomic-Based Biological Age across Cohorts
ADA Scientific Sessions 2026 AbstractAnimals
Progressive Failure of Brown Adipose Tissue Remodeling Drives Metabolic Aging
ADA Scientific Sessions 2026 AbstractHumans
Metformin Use and Epigenetic Aging in the Million Veteran Program
ADA Scientific Sessions 2026 AbstractAnimals
Role of Immune Microenvironment in Age-Related Decline of Brown Adipose Tissue
ADA Scientific Sessions 2026 AbstractAnimals
Macrophage OPA1 Prevents Age-Related Metabolic Dysfunction via the mtDNA-STING-STAT6 Pathway
ADA Scientific Sessions 2026 AbstractHuman trial
Bezisterim Treatment Is Associated with Changes in DNA Promoter Methylation Linked to Epigenetic Aging, Metabolic Risk, and Neurodegenerative Pathways
ADA Scientific Sessions 2026 AbstractAnimals
HM17321, a CRFR2 Selective UCN2 Analog, Prevents Muscle Loss and Functional Decline in Sarcopenic Mice
ADA Scientific Sessions 2026 AbstractCells
Leukemia Inhibitory Factor Promotes the Adipogenesis of Age-Enriched Adipose Progenitor Cells
ADA Scientific Sessions 2026 AbstractAnimals
Apolipoprotein A4 Improves Aging-Related Glucose Homeostasis
ADA Scientific Sessions 2026 AbstractHuman trial
Lifestyle Intervention and Exercise Reduce Adipose Tissue Senescence in Older Adults with Obesity
ADA Scientific Sessions 2026 AbstractHumans
Senotype Blueprint of the Human Endocrine Pancreas
ADA Scientific Sessions 2026 AbstractCells
Quiescence Activates p53 and Promotes Reactive Oxygen Species-Induced DNA Damage Repair in Rejuvenation of Aged Mesenchymal Stem Cells
ADA Scientific Sessions 2026 AbstractAnimals
Mechanisms and Consequences of IL-1β-Mediated Changes in β-Cell Function
ADA Scientific Sessions 2026 AbstractCells
Sex-Specific Regulation of Adipose Progenitor Cell Senescence by Lipocalin 2 via Phosphatidic Acid–Dependent mTOR Signaling Pathway
ADA Scientific Sessions 2026 AbstractAnimals
Defining the Role of P21 in β-Cell Senescence Using a Loss-of-Function Model
ADA Scientific Sessions 2026 AbstractHuman trial
Effects of Lowering Carbohydrate Amount and Glycemic Index on Whole-Body and Organ-Specific Aging Proteins and Postprandial Glucose Metabolism: The OmniCarb Trial
ADA Scientific Sessions 2026 AbstractHumans
Lean Body Mass Polygenic Score Predicts Longitudinal Muscle Loss: Evidence for Faster Decline in Adults with Diabetes
ADA Scientific Sessions 2026 AbstractHumans
Cardiovascular Health (Life’s Essential 8), Mortality Risk, and Life Expectancy in Type 2 Diabetes and Cardiometabolic Multimorbidity: Insights from UK Biobank
ADA Scientific Sessions 2026 AbstractHumans
Prediabetes Is Associated with Incident Frailty in Community-Dwelling Older Adults: A Five-Year Time-to-Event Analysis from the Bunkyo Health Study
ADA Scientific Sessions 2026 AbstractHuman trial
Association of Randomization to Metformin with Prevalent Cognitive Impairment Syndromes in the Diabetes Prevention Program Outcomes Study
ADA Scientific Sessions 2026 AbstractHumans
High Frailty among Individuals with Diabetes-Related Multimorbidity in India: Findings from a Nationwide Study
ADA Scientific Sessions 2026 AbstractHuman trial
Forty Weeks of Metformin Alters Regional Insulin Sensitivity but Not Mitochondrial Function in Insulin-Resistant Adults
ADA Scientific Sessions 2026 AbstractHuman trial
Efficacy of a Leucine-Rich EAA, Creatine HCl, and Ca-HMB Stack Coupled with Digital Twin Coaching on Sarcopenia in Type 2 Diabetes: A Double-Blind RCT
ADA Scientific Sessions 2026 AbstractHumans
Double Diabetes: A Mediator of Age-Related Cardiovascular Risk in Type 1 Diabetes: A Mediation Analysis of a Large T1D Cohort
ADA Scientific Sessions 2026 AbstractCells
Restoration of Proliferation in Rodent and Human β-Cells by Targeting Senescence
ADA Scientific Sessions 2026 AbstractHumans
Joint Association of Physical Activity and Sedentary Behavior on Mortality Stratified by Diabetes Mellitus Status: A Pooled Analysis of Six NHLBI Cohorts
ADA Scientific Sessions 2026 AbstractHumans
Early Vascular Aging in Youth-Onset Type 2 Diabetes: Associations with Glucose and Insulin Responses in the Young at Heart Study
ADA Scientific Sessions 2026 AbstractHumans
Incidence and Predictive Factors of Severe Muscle Loss among Individuals with Prediabetes: A Prospective Cohort Study
ADA Scientific Sessions 2026 AbstractHuman trial
Trajectories of Physical Activity during the Mid- to Late-Life Transition and Cognitive Impairment in Persons with Prediabetes or Type 2 Diabetes
ADA Scientific Sessions 2026 AbstractHumans
Dementia Progression with GLP-1 Receptor Agonists in People with Type 2 Diabetes and Mild Cognitive Impairment: Retrospective Cohort Study
ADA Scientific Sessions 2026 AbstractHumans
Effects of Physical Activity and Diabetes Status on Cognitive Function and Hippocampal Volume: The Bunkyo Health Study
ADA Scientific Sessions 2026 AbstractCells
Human Metabolomics Identifies Metabolite Candidates That Attenuate Skeletal Muscle Atrophy
ADA Scientific Sessions 2026 AbstractCells
ANGPTL8 Promotes Endothelial Senescence in Type 2 Diabetes via RTN4R-PI3K/AKT/FOXO3A
ADA Scientific Sessions 2026 AbstractHumans
Glucagon-Like Peptide 1 Receptor Agonists Lower the Risk of Stroke and Vascular Dementia among Individuals with Obesity
ADA Scientific Sessions 2026 AbstractCells
The Relationship between β-Cell Senescence and Incretin Signaling in Type 2 Diabetes
ADA Scientific Sessions 2026 AbstractHuman trial
Effect of Semaglutide on COVID-19–Related Complications and All-Cause Death: Pooled Analyses of the SELECT, FLOW, and SOUL Trials
ADA Scientific Sessions 2026 AbstractHumans
Low LDL-C Achieved with Lipophilic Statins Is Associated with a Higher Risk of Cognitive Dysfunction
ADA Scientific Sessions 2026 AbstractHumans
Multimorbidity Phenotypes in Diabetes and Their Association with All-Cause Mortality: A Latent Class Analysis in the UK Biobank
ADA Scientific Sessions 2026 AbstractHumans
Clinical Frailty Is a Major Determinant of Long-Term Survival in People with Diabetic Foot Ulcer Disease
ADA Scientific Sessions 2026 AbstractHumans
Longitudinal Validation of a Retinal AI Score for Cardiovascular Risk Monitoring: Validation in Korean and UK Populations
ADA Scientific Sessions 2026 AbstractHumans
Association between C-Reactive Protein–Triglyceride–Glucose Index and New-Onset Chronic Disease Incidence and Mortality: Evidence from Multinational Cohorts
ADA Scientific Sessions 2026 AbstractHumans
Multiorgan Magnetic Resonance–Based Imaging Improves Risk Stratification and Supports Treatment Allocation in Individuals with Clinical Obesity
ADA Scientific Sessions 2026 AbstractHumans
Molecular Risk Scores Enhance Type 2 Diabetes (T2D) Prediction beyond Hemoglobin A1c (HbA1c) and Body Mass Index (BMI) across Diverse Clinical Contexts
ADA Scientific Sessions 2026 AbstractHumans
Uncertainty-Calibrated Prediction of Cardiovascular–Kidney–Liver–Metabolic Disease Using Clinical Biomarkers and Plasma Proteomics
ADA Scientific Sessions 2026 AbstractHumans
Multimorbidity and Mortality in U.S. Adults with Diabetes: The Role of Age and Diabetes Duration
ADA Scientific Sessions 2026 AbstractHumans
Proteomics-Based Molecular Adiposity and Risk of Type 2 Diabetes in Diverse Population
ADA Scientific Sessions 2026 AbstractHumans
High Sensitivity Proteomics for Predicting Dementia in Older Adults with Diabetes: The Atherosclerosis Risk in Communities (ARIC) Study
ADA Scientific Sessions 2026 AbstractHumans
Cardiovascular–Kidney–Metabolic Syndrome and Risk of Mild Cognitive Impairment and Dementia in Men and Women: Findings from the UK Biobank and All of Us
ADA Scientific Sessions 2026 AbstractHumans
Associations of Total, Plant-Based, and Animal-Based Low-Carbohydrate Diets with Mortality in Individuals with Stage 3–4 CKM Syndrome
ADA Scientific Sessions 2026 AbstractHumans
Machine-Learning Modeling for T2DM Prediction in over 3 Million Adults
ADA Scientific Sessions 2026 AbstractHumans
GLP-1 Receptor Agonists and Cardiovascular Events in Adults with Obesity and Autoimmune Disease: A Target Trial Emulation
ADA Scientific Sessions 2026 AbstractIn silico
Systematic Identification of High Risk for Type 2 Diabetes in People with Mental Illness Based on Electronic Health Record Data and Machine Learning
ADA Scientific Sessions 2026 AbstractHumans
Age at Menopause Modifies the Effect of Clinical Risk Factors on Coronary Artery Disease (CAD) Incidence in Women with Type 1 Diabetes (T1D)
ADA Scientific Sessions 2026 AbstractHumans
Prescribing Trends and Comparative Risk of Type 2 Diabetes Progression in Prediabetes by Antihyperglycemic Drug Class
ADA Scientific Sessions 2026 AbstractHumans
Development and Predictive Performance of the Sensory & Social Neglect Index for Metabolic and Cognitive Decline
ADA Scientific Sessions 2026 AbstractHuman trial
Molecular Basis of Type 2 Diabetes Prevention by Semaglutide in SELECT
ADA Scientific Sessions 2026 AbstractHumans
Wearables-Derived Physical Activity Is Independently Associated with Lower Odds of Type 2 Diabetes in the All of Us Research Program
ADA Scientific Sessions 2026 AbstractHumans
Comparing Seven Adiposity Indexes in Their Ability to Predict Type 2 Diabetes Risk across Five U.S. Cohorts
ADA Scientific Sessions 2026 AbstractHumans
Integrating Lipoprotein(a) with Retinal Imaging Biomarkers for Cardiovascular Risk Assessment: UK Biobank Analysis
ADA Scientific Sessions 2026 AbstractHumans
Routine Blood Biomarkers Predict Five-Year Risk of Type 2 Diabetes in Adults without Diabetes
ADA Scientific Sessions 2026 AbstractIn silico
Concordance between QDiabetes and A Literature-Based Methodology Estimating 10-Year Type 2 Diabetes Risk in a Simulated Population
ADA Scientific Sessions 2026 AbstractHumans
A Novel Dual-Endpoint Model to Simultaneously Predict Risks of Type 2 Diabetes and Cardiovascular Disease in Prediabetes
ADA Scientific Sessions 2026 AbstractHuman trial
Long-Term Effects of Metformin and Lifestyle Interventions on Ankle-Brachial Index in the Diabetes Prevention Program Outcomes Study (DPPOS)
ADA Scientific Sessions 2026 AbstractHumans
Adherence to the EAT-Lancet Diet and Incident Diabetes: Results from the Atherosclerosis Risk in Communities (ARIC) Study
ADA Scientific Sessions 2026 AbstractHuman trial
Can 14 Days of Metformin Prevent Post-COVID Diabetes?
ADA Scientific Sessions 2026 AbstractHumans
CGM-Derived Measures in Relation to 10-Year CVD Risk in Adults without Diabetes
ADA Scientific Sessions 2026 AbstractHumans
Metabolomic Signature of Socioeconomic Position and Incident Type 2 Diabetes in the Hispanic Community Health Study/Study of Latinos
ADA Scientific Sessions 2026 AbstractHumans
Life’s Essential 8 and Mortality in U.S. Adults with Diabetes: Greater Risk Reduction Compared with Those without Diabetes
ADA Scientific Sessions 2026 AbstractHumans
Equity-Sensitive Prediabetes Screening: Discordant Phenotypes across HbA1c, FPG, and OGTT in NHANES 2005–2016
ADA Scientific Sessions 2026 AbstractHumans
The Mediating Effect of Renal Function on the Association between Life’s Essential 8 and Cognitive Function
ADA Scientific Sessions 2026 AbstractHumans
Reduction in Incident Type 2 Diabetes with National Diabetes Prevention Program/Intensive Lifestyle Intervention: Results from the Reality Research Network
ADA Scientific Sessions 2026 AbstractHumans
Comparison of Surrogate Indexes of Insulin Resistance as Predictors of Diabetes: Analysis of Five U.S. Cohorts
ADA Scientific Sessions 2026 AbstractHumans
MicroRNAs Have Potential Utility for Predicting Risk for Type 2 Diabetes in the Context of Underlying Genetic Characteristics
ADA Scientific Sessions 2026 AbstractHumans
Performance of Insulin Resistance Markers in Predicting 10-Year Cardiovascular Risk Using the Framingham Score: An NHANES-Based Study
ADA Scientific Sessions 2026 AbstractHumans
Real-World Effectiveness of Novel Antidiabetic Medications on Cardiovascular Outcomes among Medicare Beneficiaries by Race
ADA Scientific Sessions 2026 AbstractHumans
Association of Newer Glucose-Lowering Drugs with Incident Parkinsonian Disorders in Older Adults with REM Sleep Behavior Disorder and Type 2 Diabetes
ADA Scientific Sessions 2026 AbstractHumans
Cardiometabolic–Kidney Staging and Mortality Outcomes in South Asians
ADA Scientific Sessions 2026 AbstractHumans
Multimorbidity Phenotypes in Diabetes and Their Association with 10-Year Dementia Risk: A Latent Class Analysis in the UK Biobank
ADA Scientific Sessions 2026 AbstractHumans
Prediabetes Prevalence and Diabetes Incidence according to Different Prediabetes Definitions: Implications for Diabetes Prevention
ADA Scientific Sessions 2026 AbstractHuman trial
Menopausal Hormonal Status and Estradiol Use Modulate Semaglutide-Associated Weight Loss in Women: Analyses from STEP1 and SELECT
ADA Scientific Sessions 2026 AbstractHumans
SGLT2 Inhibitor Attenuates eGFR Slope in Type 2 Diabetes with UACR <30 mg/gCr
ADA Scientific Sessions 2026 AbstractHuman trial
Individualized Care Pathways vs. Usual Care to Reduce Conversion Rates from Prediabetes to Diabetes
ADA Scientific Sessions 2026 AbstractHumans
Associations between MRI-Derived Visceral Adipose Tissue and Incident Cardiometabolic Outcomes in a Large Population Cohort
ADA Scientific Sessions 2026 AbstractHumans
Clinically Significant Changes in Body Composition with Treatment of Obesity in Older Adults, 65+, with and without Diabetes
ADA Scientific Sessions 2026 AbstractHumans
Enzymatic Quantification of 2-Hydroxybutyrate: A Dynamic Biomarker for Predicting Glycemic Dysfunction
ADA Scientific Sessions 2026 AbstractHumans
Divergent Risk Profiles of Diabetes Progression in Lean and Obese Prediabetes
ADA Scientific Sessions 2026 AbstractHumans
Effectiveness and Safety of SGLT2i, GLP-1RA, and DPP-4i in Adults with T2D at Low-to-Moderate Cardiovascular Risk: An International Cohort Study
ADA Scientific Sessions 2026 AbstractHumans
Coffee Intake Timing, Metabolomics, and Diabetes: A Prospective Study in the Hispanic Community Health Study/Study of Latinos (HCHSL/SOL)
ADA Scientific Sessions 2026 AbstractHuman trial
Association of Life Events, Social Support, and Family Functioning with Risk of Developing Diabetes and the Mediating Effects of Body Mass Index (BMI) and Waist Circumference (WC)
ADA Scientific Sessions 2026 AbstractHumans
Heterogeneity of Treatment Effect of Glucagon-Like Peptide 1 Receptor Agonists for Primary Prevention of Cardiovascular Events in Type 2 Diabetes
ADA Scientific Sessions 2026 AbstractHumans
Asian Ancestry and Higher Predicted 10-Year Type 2 Diabetes Risk: Greater Insulin Resistance and Lower β-Cell Function
ADA Scientific Sessions 2026 AbstractHumans
Emulation of a Trial of Dapagliflozin in Heart Failure with Mildly Reduced or Preserved Ejection Fraction (DELIVER)
ADA Scientific Sessions 2026 AbstractHumans
Cardiovascular (CVD) Risk Factors during the Menopausal Transition among Women with Type 1 Diabetes (T1D)
ADA Scientific Sessions 2026 AbstractHumans
Prediabetes and Cognitive Impairment: The Influence of Social Risk Factors, HRS 2006–2016
ADA Scientific Sessions 2026 AbstractHumans
Prediabetes Stage and Kidney Function Decline in Nondiabetic Adults: A Metabolic Liver–Kidney Link?
ADA Scientific Sessions 2026 AbstractHumans
Where Fat Is Stored Matters More than How Much: A Large-Scale Population-Based Study Integrating DXA Phenotyping and Causal Inference
ADA Scientific Sessions 2026 AbstractHuman trial
Metabolic Effects of Active Breaks to Sitting vs. Continuous Walking in Adults with Prediabetes: Preliminary Results from the BURST2D Study
ADA Scientific Sessions 2026 AbstractHumans
Multimorbidity among Individuals with Diabetes (MAID) in India: A State-Level Analysis of a National Study
ADA Scientific Sessions 2026 AbstractHumans
Sodium-Glucose Cotransporter 2 Inhibitors and Clinical Outcomes in Type 1 Diabetes: A Target Trial Emulation Study
ADA Scientific Sessions 2026 AbstractHuman trial
A Randomized Trial of Shared-Decision Making for Type 2 Diabetes Prevention in Women with a History of Gestational Diabetes
ADA Scientific Sessions 2026 AbstractHumans
Spousal Influences on Incident Type 2 Diabetes: A Longitudinal Study of South Asians
ADA Scientific Sessions 2026 AbstractHuman trial
Sex-Specific Cognitive Responses to Prolonged Fasting in Healthy Adults: A Pilot Within-Subject Study
ADA Scientific Sessions 2026 AbstractHumans
Fragility Fracture Risk among Patients with Type 2 Diabetes Initiating Treatment with GLP-1 Receptor Agonists vs. Sulfonylureas
ADA Scientific Sessions 2026 AbstractHumans
The Clinical Outcomes of Preclinical and Clinical Obesity across Multiple Cohorts
ADA Scientific Sessions 2026 AbstractHumans
Cumulative Childbirths Show a U-shaped Association with Metabolic Syndrome in Midlife Women: The Bogalusa Heart Study
ADA Scientific Sessions 2026 AbstractHumans
Cardio–Renal–Metabolic Multimorbidity in India: Findings from a Large Community-Based Study
ADA Scientific Sessions 2026 AbstractHumans
Frailty-Guided Glycaemic Management in an Elderly Diabetic Population Based in the United Kingdom
ADA Scientific Sessions 2026 AbstractHumans
Ethnic Disparities in the Prevalence and Risk Factors of Prediabetes and Diabetes in Australian Primary Care
ADA Scientific Sessions 2026 AbstractHumans
Psoas Muscle Area Is a Useful Indicator of Muscle Mass in Older Men with Type 2 Diabetes: A Retrospective Study
ADA Scientific Sessions 2026 AbstractHumans
Longitudinal vs. Single Timepoint Proteomics Identify Novel and Distinct Diabetes Biomarkers in a Multiethnic Cohort
ADA Scientific Sessions 2026 AbstractHumans
Association of E-sdLDL-C with Disease Progression and Mortality Risk among Individuals with CKM Syndrome
ADA Scientific Sessions 2026 AbstractHumans
Unraveling the Metabolic–Cardiovascular Disease Nexus: An Epidemiological Network Analysis Identifies Central Indicators
ADA Scientific Sessions 2026 AbstractHumans
Fracture Risk with Combined SGLT2 Inhibitors and GLP-1 Receptor Agonists in Patients with Type 2 Diabetes: A Target Trial Emulation
ADA Scientific Sessions 2026 AbstractHuman trial
CT-388, a cAMP Signal-Biased GLP-1/GIP Receptor Agonist, Achieves Clinically Meaningful Weight Loss in People With Overweight/Obesity: A 48-Week Phase 2 Study
ADA Scientific Sessions 2026 AbstractHuman trial
Semaglutide and Obstructive Sleep Apnea (OSA): A Post Hoc Analysis from SELECT
ADA Scientific Sessions 2026 AbstractHuman trial
Efficacy and Safety of Dual GLP-1/GIP Receptor Agonist HDM1005 in Obese Participants without Diabetes: A Randomized, Double-Blind, Placebo-Controlled, Phase 2 Trial
ADA Scientific Sessions 2026 AbstractHuman trial
Type 2 Diabetes Remission Rate and Change in Medication Burden after 12 Months of Intermittent Fasting
ADA Scientific Sessions 2026 AbstractHuman trial
Effects of a Camp-Style Lifestyle Modification Program on Diabetes Prevention in Rural Women with Prior GDM
ADA Scientific Sessions 2026 AbstractHumans
Assessing Advanced Glycation Endproducts Using a Wearable Health Monitoring Device
ADA Scientific Sessions 2026 AbstractHumans
Evaluating Both Fasting and 1-Hour Glucose Enhances Cardiometabolic Risk Stratification by the 1-Hour Oral Glucose Tolerance Test
ADA Scientific Sessions 2026 AbstractHuman trial
The Addition of the AHA PREVENT Risk Model to NT-proBNP–Based Screening in Patients with Diabetes and Risk Factors for Heart Failure: An Exploratory Analysis of TARTAN-HF
ADA Scientific Sessions 2026 AbstractHumans
Body Mass Index and Blood Pressure Changes During and After Antiobesity Medication Use
ADA Scientific Sessions 2026 AbstractHuman trial
Cardiometabolic Effects of Semaglutide in OASIS 4 Participants by BMI Class
ADA Scientific Sessions 2026 AbstractHuman trial
Feasibility of a Salon-Based Diabetes Risk Screening and Prevention Program Referral Intervention
ADA Scientific Sessions 2026 AbstractHumans
Increased Risk for Dementia in the Setting of Traumatic Brain Injury (TBI) in Type 2 Diabetes (T2D) Patients
ADA Scientific Sessions 2026 AbstractHumans
Overall and Site-Specific Tumor Incidence and Prevalence Differ across Prediabetes Subphenotypes
ADA Scientific Sessions 2026 AbstractHumans
Circulating N-lactoyl Amino Acids, GCKR Variant, and Risk of Type 2 Diabetes in the Hispanic Community Health Study/Study of Latinos
ADA Scientific Sessions 2026 AbstractHumans
Evaluating Polygenic Risk Scores for Body Mass Index across Diverse Populations and Contexts
ADA Scientific Sessions 2026 AbstractReview
GLP-1 Receptor Agonists and Diabetic Foot Ulcer Risk: A Meta-analysis
ADA Scientific Sessions 2026 AbstractHuman trial
Metabolic Response to Oral Semaglutide in Adults with Obesity—Weight Loss and Beyond: The GAROS Prospective Study
ADA Scientific Sessions 2026 AbstractHuman trial
Efficacy and Safety of Extended-Interval PG-102, a GLP-1/GLP-2 Bispecific Agonist, in Adults with Type 2 Diabetes
ADA Scientific Sessions 2026 AbstractCells
Imeglimin and Nicotinamide Mononucleotide Ameliorate High Glucose–Induced Mitochondrial Dysfunction and Senescence in Schwann Cells
ADA Scientific Sessions 2026 AbstractHuman trial
The Effect of Prolonged Fasting and Nutritional Ketosis on Cognition
ADA Scientific Sessions 2026 AbstractHuman trial
Efficacy and Safety of Semaglutide by Race and Ethnicity in the SELECT Trial
ADA Scientific Sessions 2026 AbstractHuman trial
Early Lifestyle Changes after a Pharmacist-Led Diabetes Prevention Intervention in the New Orleans Hospitality Workforce
ADA Scientific Sessions 2026 AbstractHuman trial
Effect of Subcutaneous Semaglutide on Cardiorenal Outcomes across Type 2 Diabetes Subtypes: SUSTAIN 6 Post Hoc Analysis
ADA Scientific Sessions 2026 AbstractAnimals
GLP-1R in JBMMSCs Suppressed Jaw Bone Osteoporosis via Modulating PKA/STAT3/TET3/SHP2/ß-catenin Signaling–Induced Osteoblast Differentiation
ADA Scientific Sessions 2026 AbstractReview
Fracture Risk Associated with Tirzepatide: A Systematic Review and Meta-analysis of Randomized Controlled Trials and Real-World Evidence
ADA Scientific Sessions 2026 AbstractHuman trial
Serum Proteomics Suggest Novel Mechanisms of Action of Semaglutide in Reducing the Risk of MACE in the SELECT Trial
ADA Scientific Sessions 2026 AbstractIn silico
Cost-Effectiveness of Bariatric Surgery for Preventing Diabetes in U.S. Adults with Prediabetes and Severe Obesity: A Simulation Study
ADA Scientific Sessions 2026 AbstractHuman trial
Ertugliflozin Mitigates Blood Pressure Increments during a High-Sodium Diet in People with Type 2 Diabetes
ADA Scientific Sessions 2026 AbstractHuman trial
Long-Term Impact of Early Oral Antidiabetic Therapy on Insulin Secretion Phases in Individuals with Prediabetes (PreDM): Insights from Hyperglycemic Clamp Studies
ADA Scientific Sessions 2026 AbstractReview
Effects of SGLT2 Inhibitors on Cardiac Arrhythmias: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
ADA Scientific Sessions 2026 AbstractHuman trial
Durable Cardiometabolic Effects of Utreglutide in Metabolic Dysfunction–Associated Steatotic Liver Disease Patients with Nondiabetic and Prediabetic Status
ADA Scientific Sessions 2026 AbstractHuman trial
Assessing the Impact of a Plant-Based Diet for Diabetes Prevention: A Pilot Study
ADA Scientific Sessions 2026 AbstractHuman trial
Once-Monthly Zovaglutide (ZT002) in Adults with Overweight or Obesity and Prediabetes: A Phase 2 Subgroup Analysis
ADA Scientific Sessions 2026 AbstractHuman trial
Unidos en Salud: Using a Mobile Unit for Implementing Diabetes Screening in Rural Latino Communities
ADA Scientific Sessions 2026 AbstractHumans
Type 2 Diabetes Heterogeneity and Incident Dementia Risk Compared with Adults without Diabetes
ADA Scientific Sessions 2026 AbstractCells
Harmine and Exendin-4 Combination Attenuates Human β-Cell Senescence
ADA Scientific Sessions 2026 AbstractHumans
Cardiovascular Disease Risk Prediction in Type 1 Diabetes over 30 Years
ADA Scientific Sessions 2026 AbstractAnimals
A Trispecific GLP-1/GIP/hGH Receptor Agonist Targeting Activin Type II Receptor Drives Selective Fat Mass Reduction
ADA Scientific Sessions 2026 AbstractHuman trial
Lean Mass Effects of Anti-GDF8 (Trevogrumab) ± Anti-Activin A (Garetosmab) in People Living with Obesity Treated with Semaglutide with or without Low Lean Mass at Baseline
ADA Scientific Sessions 2026 AbstractHuman trial
Long-Term Metformin Use and Vitamin B12 Deficiency in the Diabetes Prevention Program Outcomes Study (DPPOS)
ADA Scientific Sessions 2026 AbstractHumans
Heterogeneity in Rates of Mortality among Subtypes of Prediabetes
ADA Scientific Sessions 2026 AbstractHumans
Prediabetes Screening and Metformin Use among Adults Taking Antipsychotic Medications in Primary Care
ADA Scientific Sessions 2026 AbstractHumans
Risk of Developing Cardiorenal Complications in People Living with Overweight or Obesity, with vs. without T2D
ADA Scientific Sessions 2026 AbstractHuman trial
Ertugliflozin Reduces Blood Pressure and EGFR during Both Moderate- and High-Sodium Intake in People with Type 2 Diabetes.
ADA Scientific Sessions 2026 AbstractHuman trial
Tirzepatide: Effect on Insulin Resistance and Human Fat Cells
ADA Scientific Sessions 2026 AbstractHumans
The Role of Diabetes in the Relationship between Muscle Strength and Atrial Fibrillation
ADA Scientific Sessions 2026 AbstractHuman trial
Changes in Body Composition During and After Weight Loss with Tirzepatide
ADA Scientific Sessions 2026 AbstractHuman trial
Exploring Semaglutide's Effect on the ASCVD-Related Proteomic Signature and Their Prediction of MACE in SELECT
ADA Scientific Sessions 2026 AbstractHumans
Heterogeneity of Treatment Effect of Glucagon-Like Peptide 1 Receptor Agonists for Secondary Prevention of Cardiovascular Events in Type 2 Diabetes
ADA Scientific Sessions 2026 AbstractHuman trial
Effect of Luseogliflozin on Myocardial Flow Reserve in Patients with Type 2 Diabetes Mellitus (LUCENT-J Study)
ADA Scientific Sessions 2026 AbstractHuman trial
High-Dose Semaglutide Is Associated with Preservation of Kidney Function in People Living with Obesity without Diabetes
ADA Scientific Sessions 2026 AbstractHumans
Tirzepatide Induced Cardiometabolic Transformation in Indian Patients with Obesity: A Prospective Cohort Study
ADA Scientific Sessions 2026 AbstractHumans
Individualized Slope Analysis: Optimizing Reno-Protective Pillars of Therapy
ADA Scientific Sessions 2026 AbstractHumans
Early Metabolic and Hepatic Benefits of Tirzepatide in Indian Adults with Type 2 Diabetes: Insights from Real-World Practice
ADA Scientific Sessions 2026 AbstractHumans
PCSK9 Inhibitors Are Associated with a Lower Risk of Incident Diabetes: A Global Real-World Analysis
ADA Scientific Sessions 2026 AbstractHumans
Renal Function Markers and Pancreatic Cancer Risk in Patients with Type 2 Diabetes: Findings from the Tianjin Diabetes and Health Cohort Study
ADA Scientific Sessions 2026 AbstractHuman trial
Semaglutide Improves Tissue-Specific Insulin Action and Reduces Liver Fat in Type 2 Diabetes with Spinal Cord Injury
ADA Scientific Sessions 2026 AbstractHuman trial
Physical Activity Is Associated with Less Lean Mass Loss than Caloric Restriction in People with Diabetes Undergoing Weight Loss
ADA Scientific Sessions 2026 AbstractHuman trial
Baseline Clinical and Proteomic Predictors of Glycemic Deterioration in SELECT
ADA Scientific Sessions 2026 AbstractHuman trial
Effects of Supervised Vigorous Exercise on Tissue-Specific Insulin Resistance in South Asian and Nordic Women with Previous Gestational Diabetes
ADA Scientific Sessions 2026 AbstractHumans
Cardiometabolic Risk Trajectories On and After Antiobesity Medication Use
ADA Scientific Sessions 2026 AbstractHumans
Nativity and English Language Use in Relation to Undiagnosed and Diagnosed Diabetes in U.S. Adults
ADA Scientific Sessions 2026 AbstractResearch
Rate of Age-Related EGFR Decline Differs by Insulin Dose in Type 1 Diabetes
ADA Scientific Sessions 2026 AbstractHumans
Macrovascular Outcomes in Aging Patients with Type 2 Diabetes Mellitus
ADA Scientific Sessions 2026 AbstractHuman trial
Older Adults with Prediabetes or Type 2 Diabetes Experience Poor Recovery of Muscle Power and Torque but Not Volume following 10 Days of Bed Rest
ADA Scientific Sessions 2026 AbstractHuman trial
Effect of Mazdutide on Kidney Function in Adults with Obesity or Overweight
ADA Scientific Sessions 2026 AbstractHumans
Low Hand Grip Strength Is Not Limited to Ageing: Evidence from Young Indian Adults
ADA Scientific Sessions 2026 AbstractHuman trial